Glaxo ruling benefits Big Pharma companies in Mississauga
A top court ruling that sides with GlaxoSmithKline in the British drug giant’s tax fight case with Ottawa is ‘happy news for Big Pharma,’ a tax law expert tells YourMississaugaBiz.com
Writer & Business Reporter
A top court ruling that sides with GlaxoSmithKline in the British drug giant’s tax fight case with Ottawa is ‘happy news for Big Pharma,’ a tax law expert tells YourMississaugaBiz.com
Lack of government support, company consolidation and gridlock are major challenges preventing large growth of Mississauga’s biotechnology and biomedical sector
Biotech company Genzyme Canada is applauding a move by Ottawa to speed up approval and access to orphan drugs for patients with rare diseases, but new regulations will determine the size of any new investments at its growing Mississauga plant.